thyroid associated ophthalmopathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) 18-60 years old, male or female; (2) The diagnosis of Tao (with detailed indicators attached); (3) Tao was in moderate to severe active stage (detailed indicators attached); (4) Hormone therapy is proposed.
Exclusion criteria
Exclusion criteria: (1) Severe heart, liver and kidney dysfunction; diabetes, uncontrolled hypertension, mental illness; SLE, RA and other autoimmune diseases; tuberculosis, HIV infection or AIDS patients; glucocorticoid allergy; pregnant women or breast-feeding; hepatitis vaccination within one month before enrollment; (2) He had received hormonal shock therapy, received systemic immunotherapy, including oral or intravenous corticosteroids, various immunosuppressive agents, Tao related targeted drugs, etc; (3) Orbital radiotherapy and eye surgery were performed within 1 month; (4) Compression optic neuropathy ( orbital imaging showed that the extraocular muscles compressed the optic nerve at the orbital apex, and the patient complained that the visual acuity decreased after the onset of the disease).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effectivity of hormone treatment;SEN, SPE, ACC, AUC of ROC, PPV, NPV; | — |
Countries
China
Contacts
The Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine